Blog

We’re thrilled to share that Centaur Labs, in collaboration with our esteemed partners at Brigham and Women’s Hospital (BWH), has been awarded a $750,000 grant from the Massachusetts Life Sciences Center (MLSC) through their Bits to Bytes Program. This grant, part of the Healey-Driscoll Administration’s recent $19.8 million commitment to advancing life sciences innovation, underscores the importance of our joint research in respiratory diagnostics and lung ultrasound technology.
The MLSC’s Bits to Bytes Program, established in 2018, provides support for scientific initiatives that generate and leverage large datasets to tackle vital life sciences challenges. This year, Bits to Bytes has allocated over $3 million across four transformative projects, further strengthening Massachusetts’ role as a global leader in life sciences innovation.
Governor Maura Healey announced this year’s grant recipients at the World Medical Innovation Forum, emphasizing Massachusetts’ dedication to healthcare advancement and research equity. We are deeply grateful to MLSC and the Healey-Driscoll Administration for their commitment to fostering impactful research at the intersection of artificial intelligence and healthcare.
For a demonstration of we Centaur can facilitate your AI model training and evaluation with greater accuracy, scalability, and value, Schedule a demo with Centaur.ai
Learn more about this exciting announcement here: MLSC Announcement
Partnered with SciBite to accelerate vocabulary curation, cutting the timeline by over two months through expert crowd-labeling, achieving 90.3–95.1% accuracy.
Centaur.ai is heading to HumanX 2026 to address the biggest challenge in healthcare AI: data quality. Most teams struggle not with labeling, but with measuring accuracy. Using collective intelligence and expert consensus, Centaur delivers faster, higher-quality datasets that improve model performance and support FDA-ready, defensible AI deployment.
Centaur partnered with Ryver.ai to rigorously evaluate the accuracy of their synthetic lung nodule segmentations. Using our expert-led validation framework, we found Ryver’s synthetic annotations performed on par with human experts—highlighting synthetic data’s growing role in medical AI development.